Additionally, increased ATX expression is observed in the tumor vasculature of human renal cell carcinomas upon treatment with sunitinib and the ATX/LPA signaling is thought partly responsible for the acquired resistance to sunitnib [125]. This evidence concerns the gene ENPP2 and neoplasm.